Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-25

Clinical Trial Update: Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of cyclosporine ophthalmic emulsion in patients with primary pterygium. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine ophthalmic emulsion (Cyclosporine)

Snippet

Sponsor: Allergan | Conditions: Pterygium | Phase 2 | Status: COMPLETED | Results posted: 2012-06-25